{"denomUnitsSelected":"Participants","description":"PFS was defined as the time from randomization to the first documented progressive disease (PD) or death due to any cause, whichever occurs first as assessed by RECIST 1.1. PD is defined as ≥20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of ≥5 mm. The appearance of one or more new lesions is also considered PD. PFS as assessed by BICR were presented.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 28 months","title":"Progression-free Survival (PFS)","type":"SECONDARY"}